Select Page
Home » Expert Content » Expediting Path to Clinic with OptiForm® Total Supply

Expediting Path to Clinic with OptiForm® Total Supply

Summary: MGB Biopharma, a biotech company based in Scotland, U.K. was developing a new class of anti-infective medicine based on Minor Groove Binder compounds. Learn how Catalent provided integrated formulation development, clinical trial material manufacturing, and supply and distribution services to ensure successful delivery of the kits to MGB’s patients. 

Click here to view Case Study

Related Topics